The physiological role of the interaction of VWF-GPIb : Amino acid residues of the platelet GPIb to bind VWF and the generation of knock-in mice mutated at Lys599 to A1a.
The physiological role of the interaction of VWF-GPIb : Amino acid residues of the platelet GPIb to bind VWF and the generation of knock-in mice mutated at Lys599 to A1a.
批准号:
14570974
负责人:
MATSUSHITA Tadashi
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003
中文摘要
点击翻译按钮获取中文摘要
英文摘要
At the site of vascular injury, von Willebrand factor (VWF) mediates platelet adhesion to subendothelial connective tissue through binding to N-terminal domain of the a chain of platelet glycoprotein Ib (GPIba). We have found the loss-of-function mutations generated in soluble fragment containing the N-terminal 287 amino acids of GPIbα. Mutations at Glu128, Glu172 and Asp175 specifically decreased both ristocetin-and botrocetin-induced VWF binding, suggesting that these sites are important for VWF binding of platelet GPIb. Monoclonal antibody 6D1 inhibited ristocetin-and botrocetin-induced VWF binding and a mutation at Glu125 specifically reduced the binding to 6D1. In contrast, antibody HPL7 had no effect for VWF binding and mutant E121A reduced the HPL7 binding. Mutations at His12 and Glu14 decreased the ristocetin-induced VWF binding with normal botrocetin-induced binding. Crystallographic modeling of the VWF-GPIba complex indicated that Glu128 and Asp175 form VWF binding sites and … More the binding of 6D1 to Glu125 interrupts the VWF binding of Glu128 but HPL7 binding to Glu121 has no effect on VWF binding. Moreover, His12 and Glu14 contact with Glu613 and Arg571 of VWF A1 domain whose mutations had shown similar phenotype. Using targeted gene disruption and Cre-loxP gene excision technique, we investigated the role of VWF-GPIb in normal hemostasis. Oligonucleotide primer were used to obtain a partial cDNA of mouse VWF in from mRNA of C57BL/6J mice using RT-PCR. The resulting PCR product was used as a probe to isolate a genomic clone containing a segment of mouse VWF gene from a 129SVJ lambda FIX II genomic library. A targeting vector was constructed for homologous recombination in embryonic stem cells. It was based on a vector pBS/MC1DTpA+loxpGKneoW and the VWF gene fragments. The generation of targeted D3 embryonic stem (ES) cells and blastocyst injection were prepared to perform the knock-in strategies. Obtained findings indicates the novel binding sites required for VWF binding of human GPIbα Less
期刊论文(54)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Kunishima S: "Immunofluorescence analisis of neutrophil nonmuscle myosin heavy chain-A in MYH 9 disorders : association of subcellular localization with MYH9 mutations"Lab Invest. 83. 115-122 (2003)
Kunishima S:“MYH 9 疾病中中性粒细胞非肌肉肌球蛋白重链 A 的免疫荧光分析:亚细胞定位与 MYH9 突变的关联”Lab Invest。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kunishima S: "Novel nonsense mutation in the platelet glycoprotein Ibbeta gene associated with Bernard-Soulier syndrome"Am J Hematol. 71. 279-284 (2002)
Kunishima S:“与 Bernard-Soulier 综合征相关的血小板糖蛋白 Ibbeta 基因中的新型无义突变”Am J Hematol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yamada T: "Enzyme immunoassay for measurement of murine plasminogen activator inhibitor-1, employing a specific antibody produced by the DNA vaccine method"Thromb Res. 111. 285-291 (2003)
Yamada T:“用于测量鼠纤溶酶原激活剂抑制剂-1的酶免疫测定法,采用由DNA疫苗方法产生的特异性抗体”Thromb Res。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kunishima S: "Immunofluorescence analysis of neutrophil nonmuscle myosin heavy chain-A in MYH9 disorders : association of subcellular localization with MYH9 mutations"Lab Invest. 83. 115-122 (2003)
Kunishima S:“MYH9 疾病中中性粒细胞非肌肉肌球蛋白重链 A 的免疫荧光分析:亚细胞定位与 MYH9 突变的关联”Lab Invest。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yamamoto K: "Plasminogen activator inhibitor-1 is a major stress-regulated gene : implications for stress-induced thrombosis in aged individuals"Proc Natl Acad Sci USA. 99. 890-895 (2002)
Yamamoto K:“纤溶酶原激活剂抑制剂-1 是一种主要的应激调节基因:对老年人应激诱导的血栓形成的影响”Proc Natl Acad Sci USA。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 17 条
Separation of VWF domain function using gene-targeted mic
-
批准号:22591059
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.33万
-
财政年份:2010
-
负责人:MATSUSHITA Tadashi
-
依托单位:
Regulation of thrombotic microangiopathic anemia (TMA) by controlling von Willebrand factor function by specific monoclonal antibody
-
批准号:19591104
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.33万
-
财政年份:2007
-
负责人:MATSUSHITA Tadashi
-
依托单位:
Development of time-resolved X-ray reflectometory for real-time studies of structural changes of thin films
-
批准号:19360023
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.81万
-
财政年份:2007
-
负责人:MATSUSHITA Tadashi
-
依托单位:
Fatal thrombosis of antithrombin deficient mice is rescued differently in the heart and liver by intercrossing with low tissue factor mice
-
批准号:16590933
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.05万
-
财政年份:2004
-
负责人:MATSUSHITA Tadashi
-
依托单位:
Identification of the regulatory elements of human von Willebrand factor for binding to platelet GPlb.
-
批准号:12670983
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.11万
-
财政年份:2000
-
负责人:MATSUSHITA Tadashi
-
依托单位:
Development of Strutural Method for the Study of Two Dimensional Molecular Arrangement of Monolayers on the Surfaces of Water and Baseplate
-
批准号:62850010
-
项目类别:Grant-in-Aid for Developmental Scientific Research
-
资助金额:$5.44万
-
财政年份:1987
-
负责人:MATSUSHITA Tadashi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
“活血通络”法调控vWF/GPIb轴抑制血小板聚集改善冠状动脉慢血流的机制研究
-
批准号:JCZRLH202600688
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
GPIbα-CAAR-T特异性清除自身反应性B细胞治疗ITP疾病的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:刘俊岭
-
依托单位:
血小板GPIbα对肿瘤血行转移的调控作用及其机制研究
-
批准号:82230003
-
项目类别:重点项目
-
资助金额:261万元
-
批准年份:2022
-
负责人:戴克胜
-
依托单位:
Zyxin对血小板生成和GPIb-IX复合物膜表面表达的调控作用及机制研究
-
批准号:82070121
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2020
-
负责人:闫荣
-
依托单位:
适配子Let7binhibitor-PS通过GPIb抑制血小板活化及抗栓机制研究
-
批准号:82070197
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:夏荣
-
依托单位:
GPIbα-vWF 相互作用介导肿瘤血行转移的机制研究
-
批准号:19ZR1413800
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2019
-
负责人:梁欣
-
依托单位:
抗血小板GPIbα抗体介导ITP的致病机制异质性研究
-
批准号:81900124
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2019
-
负责人:徐淼
-
依托单位:
糖蛋白GPIb-IX-V调控肺部巨核细胞形成前血小板的机制研究
-
批准号:81970127
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:戴菁
-
依托单位:
GPIb蛋白在血小板αIIb启动子介导的甲型血友病基因治疗中的作用
-
批准号:81800110
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:陈娟
-
依托单位:
GPIb-IX-V受体介导动脉血栓形成的调控机制及其抑制剂研究
-
批准号:81800129
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:张琳
-
依托单位: